Importance of vascular phenotype by basic fibroblast growth factor, and influence of the angiogenic factors basic fibroblast growth factor/fibroblast growth factor receptor-1 and ephrin-A1/EphA2 on melanoma progression.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  American Journal of Pathology

• Publication date

  2002-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/S0002-9440(10)64922-XPMID 11891198PMCID PMC1867162
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Molecular regulation of tumor cell vasculogenic mimicry by tyrosine phosphorylation: role of epithelial cell kinase (Eck/EphA2).

  2001cited by this paper
• VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

  2001cited by this paper
• Expression and functional significance of VE-cadherin in aggressive human melanoma cells: Role in vasculogenic mimicry

  2001cited by this paper
• Localization of vascular endothelial growth factor‐D in malignant melanoma suggests a role in tumour angiogenesis

  2001cited by this paper
• Antiangiogenic agents and their promising potential in combined therapy.

  2001cited by this paper
• Microarrays of bladder cancer tissue are highly representative of proliferation index and histological grade

  2001cited by this paper
• Molecular determinants of ovarian cancer plasticity.

  2001cited by this paper
• Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors.

  2001cited by this paper
• Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth.

  2001cited by this paper
• Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

  2001cited by this paper
• Basic fibroblast growth factor and ultraviolet B transform melanocytes in human skin.

  2001cited by this paper
• Modulation of angiogenesis and tumorigenicity of human melanocytic cells by vascular endothelial growth factor and basic fibroblast growth factor.

  2001cited by this paper
• Lymphatic microvessel density as a novel prognostic factor in early‐stage invasive cervical cancer

  2001cited by this paper
• Expresson of vascular endothelial growth factor, its receptors (FLT-1, KDR) and TSP-1 related to microvessel density and patient outcome in vertical growth phase melanomas.

  2001cited by this paper
• Prognostic significance of periodic acid-Schiff-positive patterns in primary cutaneous melanoma.

  2001cited by this paper
• Human melanoma progression in skin reconstructs : biological significance of bFGF.

  2000cited by this paper
• [Angiogenesis and tumor progression in melanoma].

  2000cited by this paper
• Vascular endothelial growth factor, interleukin 8, platelet-derived endothelial cell growth factor, and basic fibroblast growth factor promote angiogenesis and metastasis in human melanoma xenografts.

  2000cited by this paper
• IL-8 expression in malignant melanoma: implications in growth and metastasis.

  2000cited by this paper
• Expression and function of angiopoietin-1 in breast cancer

  2000cited by this paper
• Angiogenesis and cancer metastasis.

  2000cited by this paper
• Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma.

  2000cited by this paper
• Angiogenic balance in human melanoma: Expression of VEGF, bFGF, IL‐8, PDGF and angiostatin in relation to vascular density of xenografts in vivo

  2000cited by this paper
• Mosaic blood vessels in tumors: frequency of cancer cells in contact with flowing blood.

  2000cited by this paper
• Fibroblast growth factors are required for efficient tumor angiogenesis.

  2000cited by this paper
• Nesbit M, Nesbit HK, Bennett J, Andl T, Hsu MY, Dejesus E, McBrian M, Gupta AR, Eck SL, Herlyn MBasic fibroblast growth factor induces a transformed phenotype in normal human melanocytes. Oncogene 18: 6469-6476

  1999cited by this paper
• Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.

  1999cited by this paper
• Co-expression of vascular endothelial growth factor (VEGF) and its receptors (flk-1 and flt-1) in hormone-induced mammary cancer in the Noble rat

  1999cited by this paper
• Melanoma-associated expression of vascular endothelial growth factor and its receptors FLT-1 and KDR

  1999cited by this paper
• Vascular endothelial growth factor-C expression in human prostatic carcinoma and its relationship to lymph node metastasis

  1999cited by this paper
• Expression of interleukin‐8 detected by in situ hybridization correlates with worse prognosis in primary cutaneous melanoma

  1999cited by this paper
• Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry.

  1999cited by this paper
• Expression of angiogenesis stimulators and inhibitors in human thyroid tumors and correlation with clinical pathological features.

  1999cited by this paper
• Molecular and biological properties of vascular endothelial growth factor

  1999cited by this paper
• Clinical applications of angiogenic growth factors and their inhibitors

  1999cited by this paper
• Up‐regulation of ephrin‐a1 during melanoma progression

  1999cited by this paper
• Role of Interleukin-8 in Tumor Growth and Metastasis of Human Melanoma

  1999cited by this paper
• Expression and functional significance of vascular endothelial growth factor receptors in human tumor cells.

  1999cited by this paper
• Prognostic significance of angiogenesis and Ki-67, p53, and p21 expression: a population-based endometrial carcinoma study.

  1999cited by this paper
• Expression of interleukin-8 in primary and metastatic malignant melanoma of the skin.

  1999cited by this paper
• Basic fibroblast growth factor induces a transformed phenotype in normal human melanocytes

  1999cited by this paper
• The expression of basic fibroblast growth factor (bFGF) in tumor-associated stromal cells and vessels is inversely correlated with non-small cell lung cancer progression.

  1999cited by this paper
• Angiogenesis is prognostically important in vertical growth phase melanomas.

  1999cited by this paper
• VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer.

  1999cited by this paper
• Expression of growth factors, growth inhibiting factors, and their receptors in invasive breast cancer. I: An inventory in search of autocrine and paracrine loops

  1998cited by this paper
• Vascular endothelial growth factor upregulates the expression of matrix metalloproteinases in vascular smooth muscle cells: role of flt-1.

  1998cited by this paper
• Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors.

  1998cited by this paper
• p53, vessel count, and vascular endothelial growth factor expression in human colon cancer

  1998cited by this paper
• Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra‐ocular tumours

  1998cited by this paper
• Tissue microarrays for high-throughput molecular profiling of tumor specimens

  1998cited by this paper
• Basic fibroblast growth factor is a morphogenic modulator in kidney vessel development.

  1998cited by this paper
• Tyrosine phosphorylation of L1 family adhesion molecules: Implication of the Eph kinase Cek5

  1997cited by this paper
• Vascular permeability factor (Vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast

  1997cited by this paper
• Transition of horizontal to vertical growth phase melanoma is accompanied by induction of vascular endothelial growth factor expression and angiogenesis

  1997cited by this paper
• Combined analysis of p53 and vascular endothelial growth factor expression in colorectal carcinoma for determination of tumor vascularity and liver metastasis

  1997cited by this paper
• The Eph family of receptors.

  1997cited by this paper
• Angiogenesis and malignant melanoma. Angiogenesis is related to the development of vertical (tumorigenic) growth phase

  1997cited by this paper
• Expression of fibroblast growth factor receptors in naevus-cell naevus and malignant melanoma

  1997cited by this paper
• Enhanced expression of vascular endothelial growth factor in metastatic melanoma.

  1997cited by this paper
• bFGF and tumor angiogenesis — Back in the limelight?

  1997cited by this paper
• Antisense targeting of basic fibroblast growth factor and dibroblast growth factor receptor-1 in human melanomas blocks intratumoral angiogenesis and tumor growth

  1997cited by this paper
• Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.

  1997cited by this paper
• Hyperplasia of lymphatic vessels in VEGF-C transgenic mice.

  1997cited by this paper
• The Eph family in the patterning of neural development.

  1997cited by this paper
• Expression of the angiogenic factors vascular endothelial cell growth factor, acidic and basic fibroblast growth factor, tumor growth factor beta-1, platelet-derived endothelial cell growth factor, placenta growth factor, and pleiotrophin in human primary breast cancer and its relation to angiogenes

  1997cited by this paper
• Patterns and Emerging Mechanisms Review of the Angiogenic Switch during Tumorigenesis

  1996cited by this paper
• The Vascular Endothelial Growth Factor Receptor Flt-1 Mediates Biological Activities

  1996cited by this paper
• Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis.

  1996cited by this paper
• The prognostic significance of basic fibroblast growth factor in cutaneous malignant melanoma

  1996cited by this paper
• Development of retinal vasculature is mediated by hypoxia-induced vascular endothelial growth factor (VEGF) expression by neuroglia

  1995cited by this paper
• Melanoma cell lines express VEGF receptor KDR and respond to exogenously added VEGF.

  1995cited by this paper
• Cell Signalling: Receptor orphans find a family

  1995cited by this paper
• Protein B61 as a new growth factor: expression of B61 and up-regulation of its receptor epithelial cell kinase during melanoma progression.

  1995cited by this paper
• Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development.

  1995cited by this paper
• Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

  1995cited by this paper
• Angiogenesis in cancer, vascular, rheumatoid and other disease

  1995cited by this paper
• Tumor vascularity is not a prognostic factor for malignant melanoma of the skin.

  1995cited by this paper
• Extent of vascularization as a prognostic indicator in thin (< 0.76 mm) malignant melanomas.

  1994cited by this paper
• IL-8 produced by human malignant melanoma cells in vitro is an essential autocrine growth factor.

  1993cited by this paper
• Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma.

  1993cited by this paper
• Human melanoma cells but not normal melanocytes express vascular endothelial growth factor receptors.

  1993cited by this paper
• The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor.

  1992cited by this paper
• Angiogenesis during tumor progression in human malignant melanoma.

  1992cited by this paper
• Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma.

  1992cited by this paper
• Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor.

  1992cited by this paper
• Melanocytic Tumors of the Skin. Atlas of Tumor Pathology

  1992cited by this paper
• Interleukin-8 as a macrophage-derived mediator of angiogenesis.

  1992cited by this paper
• Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma.

  1991cited by this paper
• A novel immediate-early response gene of endothelium is induced by cytokines and encodes a secreted protein

  1990cited by this paper
• Proliferation of human malignant melanomas is inhibited by antisense oligodeoxynucleotides targeted against basic fibroblast growth factor.

  1989cited by this paper
• bFGF as an autocrine growth factor for human melanomas.

  1988cited by this paper
• Atlas of tumor pathology

  1954cited by this paper
• Regression Models and Life-Tables

  year unknowncited by this paper

• Prognostic value of immune biomarkers in melanoma loco-regional metastases

  2025cites this paper
• A Panel of Potential Serum Markers Related to Angiogenesis, Antioxidant Defense and Hypoxia for Differentiating Cutaneous Squamous Cell Carcinomas from Actinic Keratoses

  2024cites this paper
• The specific shapes of capillaries are associated with worse prognosis in patients with invasive breast cancer

  2024cites this paper
• Prognostic value of receptor tyrosine kinases in malignant melanoma patients: A systematic review and meta-analysis of immunohistochemistry

  2022influential citation
• Evaluating the Expression of Candidate Homeobox Genes and Their Role in Local-Site Inflammation in Mucosal Tissue Obtained from Children with Non-Syndromic Cleft Lip and Palate

  2021cites this paper
• The Clinical Impact of the EPH/Ephrin System in Cancer: Unwinding the Thread

  2021influential citation
• Paradigms of vascularization in melanoma: Clinical significance and potential for therapeutic targeting.

  2020cites this paper
• Effect of EphA2 knockdown on melanoma metastasis depends on intrinsic ephrinA1 level

  2020cites this paper
• sFRP2 Supersedes VEGF as an Age-related Driver of Angiogenesis in Melanoma, Affecting Response to Anti-VEGF Therapy in Older Patients

  2020cites this paper
• Antibody Based Targeted Interventions for the Diagnosis and Treatment of Skin Cancers.

  2020cites this paper
• Fibroblast Growth Factor Receptor Signaling in Skin Cancers

  2019cites this paper
• SIRT2 Contributes to the Resistance of Melanoma Cells to the Multikinase Inhibitor Dasatinib

  2019cites this paper
• Prognostic value of uPAR expression and angiogenesis in primary and metastatic melanoma

  2019cites this paper
• Microvessel Density in Patients with Cutaneous Melanoma: An Up-to-Date Systematic Review and Meta-Analysis

  2017cites this paper
• Tissue-Based Biomarkers of Tumor-Vascular Interactions

  2017cites this paper
• The Tumor Microenvironment in Cutaneous Melanoma: Friend or Foe

  2017cites this paper
• Prognostic impact and concordance of TERT promoter mutation and protein expression in matched primary and metastatic cutaneous melanoma

  2017cites this paper
• Matrix Metalloproteinases in Melanoma with and without Regression

  2017cites this paper
• Basic fibroblast growth factor as a potential biomarker for diagnosing malignant tumor metastasis in women

  2017cites this paper
• Clinical and biological determinants of melanoma progression: Should all be considered for clinical management?

  2016cites this paper
• Expression von EphA 2 in metastasierten und nicht metastasierten primären uvealen Melanomen Expression of EphA 2 in Metastatic and Non-Metastatic Primary Uveal Melanoma

  2016cites this paper
• Novel anti-EPHA2 antibody, DS-8895a for cancer treatment

  2016cites this paper
• Avaliação da terapia fotodinâmica em um modelo tumoral em membrana corioalantóica

  2016cites this paper
• Proteolytic regulation of the EphB4-Ephrin-B2 signalling axis in prostate cancer

  2016cites this paper
• BRAF-V600E expression in primary nodular melanoma is associated with aggressive tumour features and reduced survival

  2016cites this paper
• Expression von EphA2 in metastasierten und nicht metastasierten primären uvealen Melanomen

  2016cites this paper
• [FGF/FGFR signalling: Implication in oncogenesis and perspectives].

  2015cites this paper
• Aberrant expression of hSef and Sprouty4 in endometrial adenocarcinoma

  2015cites this paper
• Expression of EphA 2 protein is positively associated with age , tumor size and Fuhrman nuclear grade in clear cell renal cell carcinomas

  2015cites this paper
• Microvessel density, lymphovascular density, and lymphovascular invasion in primary cutaneous melanoma-correlation with histopathologic prognosticators and BRAF status.

  2015cites this paper
• A mechanistic study on the anti-melanoma action of quercetin

  2015cites this paper
• Expression of EphA2 protein is positively associated with age, tumor size and Fuhrman nuclear grade in clear cell renal cell carcinomas.

  2015cites this paper
• Cutaneous Malignant Melanoma: Update on Diagnostic and Prognostic Biomarkers

  2014cites this paper
• Established and Emerging Biomarkers in Cutaneous Malignant Melanoma

  2014cites this paper
• Predictive biomarkers for dasatinib treatment in melanoma

  2014cites this paper
• Dual VEGF/VEGFR inhibition in advanced solid malignancies

  2014cites this paper
• Nestin expression is associated with aggressive cutaneous melanoma of the nodular type

  2014cites this paper
• Neuropilin‐2 gene expression correlates with malignant progression in cutaneous melanoma

  2014cites this paper
• Long Pentraxin-3 Inhibits Epithelial–Mesenchymal Transition in Melanoma Cells

  2013cites this paper
• Prognostic Value of Microvessel Density and p53 Expression on the Locoregional Metastasis and Survival of the Patients With Head and Neck Squamous Cell Carcinoma

  2013cites this paper
• Structure-Function Relationship of the Ligand-Binding Domain of the Fibroblast Growth Factor Receptor

  2013cites this paper
• in Melanoma Cells Mesenchymal Transition

  2013cites this paper
• Mechanisms of neovascularization and resistance to anti-angiogenic therapies in glioblastoma multiforme

  2013cites this paper
• Experimental hypoxia does not influence gene expression and protein synthesis of Eph receptors and ephrin ligands in human melanoma cells in vitro

  2013cites this paper
• Endometrial carcinoma: a step closer to individualized therapy? Exploring transcriptional alterations in relation to prognostic biomarkers

  2013cites this paper
• Eph receptors and their ligands: promising molecular biomarkers and therapeutic targets in prostate cancer.

  2013cites this paper
• Therapeutic Kinase Inhibitors

  2012cites this paper
• The Eph/Ephrin family in cancer metastasis: communication at the service of invasion

  2012cites this paper
• Beyond BRAF in melanoma.

  2012cites this paper
• Anti-Angiogenesis Therapy in Melanoma

  2012cites this paper
• From genes to drugs: targeted strategies for melanoma

  2012cites this paper
• Irradiation affects cellular properties and Eph receptor expression in human melanoma cells

  2012cites this paper
• Clinical significance of EphA2 expression in squamous-cell carcinoma of the head and neck

  2011cites this paper
• Similar expression to FGF (Sef) reduces endometrial adenocarcinoma cells proliferation via inhibiting fibroblast growth factor 2-mediated MAPK/ERK signaling pathway.

  2011cites this paper
• A new era: melanoma genetics and therapeutics

  2011cites this paper
• Receptor tyrosine kinases and their activation in melanoma

  2011influential citation
• Reactive oxygen species driven angiogenesis by inorganic nanorods.

  2011cites this paper
• Fibroblast growth factors and their receptors in cancer.

  2011cites this paper
• Emerging strategies for EphA2 receptor targeting for cancer therapeutics

  2011cites this paper
• Adenosine and its receptors in the heart: regulation, retaliation and adaptation.

  2011cites this paper
• Epha2 is a Critical Oncogene in Melanoma

  2011cites this paper
• The role of the Eph and ephrin proteins in prostate cancer

  2011cites this paper
• Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma.

  2010influential citation
• Ephrin expression and function in cancer.

  2010cites this paper
• Ki-67 expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma

  2010cites this paper
• Molecular therapy for melanoma: Useful and not useful targets

  2010cites this paper
• Clinical signi W cance of EphA 2 expression in squamous-cell carcinoma of the head and neck

  2010cites this paper
• Tissue biomarkers for prognosis in cutaneous melanoma: a systematic review and meta-analysis.

  2009cites this paper
• Melanoma biomarkers: current status and vision for the future

  2009cites this paper
• Long-lasting molecular changes in human skin after repetitive in situ UV irradiation.

  2009cites this paper
• The Proangiogenic Factor Ephrin-A1 Is Up-Regulated in Radioresistant Murine Tumor by Irradiation

  2009cites this paper
• EphA2 as a promoter of melanoma tumorigenicity

  2009cites this paper
• Molecular and prognostic markers in prostate cancer

  2008cites this paper
• FGF2 transcript levels are positively correlated with EGF and IGF-1 in the malignant endometrium.

  2008cites this paper
• Tumor necrosis is associated with increased α v β 3 expression and poor prognosis in nodular cutaneous melanomas

  2008cites this paper
• Mutation analysis of the EGFR–NRAS–BRAF pathway in melanomas from black Africans and other subgroups of cutaneous melanoma

  2008cites this paper
• DNA microarray technology in dermatology.

  2008cites this paper
• Tumor necrosis is associated with increased alphavbeta3 integrin expression and poor prognosis in nodular cutaneous melanomas

  2008cites this paper
• Low BMI-1 expression is associated with an activated BMI-1-driven signature, vascular invasion, and hormone receptor loss in endometrial carcinoma

  2008cites this paper
• Loss of BMI-1 expression is associated with clinical progress of malignant melanoma

  2008cites this paper
• The role of EphA2 RTK in breast cancer cell malignancy and tumor angiogenesis.

  2008cites this paper
• Intracellular trafficking of endogenous fibroblast growth factor‐2

  2008cites this paper
• Is It a False Friend

  2007cites this paper
• Heme Oxygenase-1 in Tumors: Is It a False Friend?

  2007cites this paper
• ADAMTS1 i TFPI-2: Estudi de la seva interacció funcional i les implicacions en la plasticitat tumoral.

  2007cites this paper
• The Homeobox Gene GAX Activates p21WAF1/CIP1 Expression in Vascular Endothelial Cells through Direct Interaction with Upstream AT-rich Sequences*

  2007cites this paper
• A Switch from E-Cadherin to N-Cadherin Expression Indicates Epithelial to Mesenchymal Transition and Is of Strong and Independent Importance for the Progress of Prostate Cancer

  2007cites this paper
• Loss of p53 and overexpression of EphA2 predict poor prognosis for ovarian cancer patients

  2007cites this paper
• ARMS depletion facilitates UV irradiation induced apoptotic cell death in melanoma.

  2007cites this paper
• Protein expression of melanocyte growth factors (bFGF, SCF) and their receptors (FGFR‐1, c‐kit) in nevi and melanoma

  2007cites this paper
• Fibroblast growth factor-2 in hyperplastic pituitaries of D2R knockout female mice.

  2007cites this paper
• Deciphering the signaling events that promote melanoma tumor cell vasculogenic mimicry and their link to embryonic vasculogenesis: Role of the Eph receptors

  2007cites this paper
• Comparison of EphA Receptor Tyrosine Kinases and ephrinA Ligand Expression to EphB-ephrinB in Vascularized Corneas

  2007cites this paper
• The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma.

  2006cites this paper
• Cell Motility in Cancer Invasion and Metastasis

  2006cites this paper
• Novel biomarkers in malignant melanoma.

  2006cites this paper
• Motility in Melanoma Progression

  2006cites this paper
• Expression of the EphA2 gene in esophageal carcinoma tissues

  2006cites this paper
• Expression of enhancer of zeste homologue 2 is significantly associated with increased tumor cell proliferation and is a marker of aggressive breast cancer.

  2006cites this paper
• FGFR4 Arg388 allele correlates with tumour thickness and FGFR4 protein expression with survival of melanoma patients

  2006cites this paper